Currently, no clinically significant changes in the absorption or action of co-administered oral medications have been reported, but patients with impaired kidney function taking medications that require weight-based dosing warrant more frequent monitoring
Set a reminder
Muscle loss during GLP-1 weight loss is typically linked to: Low protein intake Large calorie deficits Reduced resistance training Rapid or unstructured weight loss Weight loss always includes a mix of fat and lean mass loss, but research on GLP-1 medications suggests that while fat loss is predominant, some lean mass loss can occur depending on dietary intake and physical activity levels
Semaglutide: a medicine to manage type 2 diabetes or obesity
"Let me say this clearly: If you see an ad with my face on a 'product,' its fake." The BBB says scammers are capitalizing on the public's familiarity with GLP-1 drugs
We limited the dataset to hospitals with CY 2024 claims data that we used to model the impact of the CY 2026 APC relative payment weights (3,395 hospitals) because it is appropriate to use the same set of hospitals that we are using to calibrate the modeled CY 2026 OPPS
